JOHNSON BRENT 4
4 · IRADIMED CORP · Filed Apr 14, 2020
Insider Transaction Report
Form 4
IRADIMED CORPIRMD
JOHNSON BRENT
Exec. VP, Sales & Marketing
Transactions
- Sale
Common Stock
2020-04-09$20.11/sh−4,000$80,440→ 2,940 total - Tax Payment
Common Stock
2020-04-10$19.99/sh−1,342$26,827→ 3,663 total - Exercise/Conversion
Common Stock
2020-04-09$1.48/sh+4,000$5,920→ 6,940 total - Exercise/Conversion
Restricted Stock Units
2020-04-10−2,065→ 0 total→ Common Stock (2,065 underlying) - Exercise/Conversion
Common Stock
2020-04-10+2,065→ 5,005 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-04-09−4,000→ 114,474 totalExercise: $1.48Exp: 2023-12-31→ Common Stock (4,000 underlying)
Footnotes (5)
- [F1]The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.
- [F2]This transaction was executed in multiple trades at prices ranging from $20.00 to $20.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Restricted stock units convert into common stock on a one-for-one basis.
- [F4]On December 14, 2016, December 4, 2017, and December 7, 2018 the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017, December 4, 2018 and December 7, 2019 respectively. The scheduled vestings were accelerated by the registrant, and the restricted stock units became vested as of April 10, 2020. Upon vesting, the reporting person received a number of shares of common stock equal to the number of restricted stock units that vested.
- [F5]This option, representing a right to purchase a total of 199,759 shares, was granted on December 31, 2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. 49,939 shares from this award were previously exercised in December 2015.